Back to Authors

Stalbovskaya, Viktoriya

A5046147242 | I4210135431

Mayo Clinic

Merus (Netherlands)

Citations 2

Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer

New England Journal of Medicine | February 5, 2025 | Volume: 392 | Issue: 6 | Pages: 566-576

10.1056/nejmoa2405008 | PMID 39908431

ReTHINK: A randomized, double-blind, placebo-controlled, multicenter, phase 3 study of ruxolitinib in early myelofibrosis patients.

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: TPS7080-TPS7080

10.1200/jco.2016.34.15_suppl.tps7080